GGrantIndex
Sort

46,585 grants matching heart failure

PKCa Signaling Regulates Contractility and Heart Failure

$408,696
Jeffery D Molkentin · University Of Cincinnati · P50 · FY2007 · HL

Third Coast HIV-Related Cardiovascular and Sleep Disorders K12 Career Development Program

$408,675
John Schneider · University Of Chicago · K12 · FY2020 · HL

Chemoreflex in Heart Failure

$408,672
Harold D Schultz · University Of Nebraska Medical Center · P01 · FY2009 · HL

Chemoreflex in Heart Failure

$408,672
Harold D Schultz · University Of Nebraska Medical Center · P01 · FY2010 · HL

Chemoreflex in Heart Failure

$408,672
Harold D Schultz · University Of Nebraska Medical Center · P01 · FY2012 · HL

The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance

$408,625
Mohamed H Sayegh · Boston Children'S Hospital · R01 · FY2010 · AI

Animal Model, Tissue/Cell Harvesting, and Phenotyping Core

$408,591
Theodore P Abraham · Johns Hopkins University · P01 · FY2013 · HL

TYPE I TGF-BETA RECEPTOR AND CARDIAC MUSCLE

$408,588
Baylor College Of Medicine · R01 · FY2003 · HL

MN Cardiovascular Cell Therapy Clinical Research Network: From AMI to CHF

$408,569
Timothy D Henry · University Of Minnesota · U01 · FY2010 · HL

VACCINE DISCOVERY FOR TRYPANOSOMA CRUZI

$408,568
University Of Georgia (Uga) · P01 · FY2003 · AI

Fibrotic Signaling in Cardiomyopathy

$408,527
Jeffrey Robbins · Cincinnati Childrens Hosp Med Ctr · P01 · FY2014 · HL

SIRT1 as a regulator of health and lifespan of mammals

$408,523
David A. Sinclair · Harvard Medical School · R37 · FY2015 · AG

Effect of Bariatric Surgery on Insulin Resistance &CVD

$408,508
University Of Pittsburgh At Pittsburgh · U01 · FY2004 · DK

Bacteria-Triggered Antimicrobial Release from Microgel-Modified Surfaces

$408,494
Matthew R Libera · Stevens Institute Of Technology · · FY2016 · MPS

Myofilament Function in Human Heart Failure

$408,464
Peter Buttrick · University Of Colorado Denver · R01 · FY2008 · HL

Blood Pressure Control During Exercise in Heart Failure

$408,447
Donal S. O'Leary · Wayne State University · R01 · FY2018 · HL

Blood Pressure Control During Exercise in Heart Failure

$408,447
Donal S. O'Leary · Wayne State University · R01 · FY2019 · HL

The ISCHEMIA Trial - EQOL

$408,447
Daniel B Mark · Duke University · U01 · FY2015 · HL

Blood Pressure Control During Exercise in Heart Failure

$408,447
Donal S. O'Leary · Wayne State University · R01 · FY2020 · HL

Blood Pressure Control During Exercise in Heart Failure

$408,447
Donal S. O'Leary · Wayne State University · R01 · FY2017 · HL

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling

$408,359
Murat Bastepe · Massachusetts General Hospital · R01 · FY2020 · DK

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling

$408,359
Murat Bastepe · Massachusetts General Hospital · R01 · FY2021 · DK

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling

$408,359
Murat Bastepe · Massachusetts General Hospital · R01 · FY2022 · DK

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling

$408,359
Murat Bastepe · Massachusetts General Hospital · R01 · FY2023 · DK

1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial

$408,351
Stuart Berger · Lurie Children'S Hospital Of Chicago · UH3 · FY2024 · HL